Peps
What is N-Acetyl Selank?
N-Acetyl Selank is a modified Selank label. The selected clinical report studied parent Selank, not a verified N-acetylated variant; its findings are included as related background.
Biological role or research focus
Modified-peptide evidence boundaries.
The intervention was parent Selank. Its report cannot confirm efficacy or safety of N-Acetyl Selank, and abstract-only methods limit interpretation.
Names you may encounter
Acetyl Selank · NA-Selank
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- N-acetylated Selank variant label
- Research focus
- Modified-peptide evidence boundaries
- Featured evidence
- Related parent compound · Human comparative report
- Source check
- October 4, 2026
Biology & proposed mechanism
A terminal modification can change a peptide’s properties. Parent-compound observations do not establish the modified variant’s mechanism, exposure, or clinical effect.
Research context & identity
No exact-variant human clinical publication was verified for this page’s selected evidence. This is an explicit evidence gap, rather than a claim that the modified product has been clinically validated.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Related parent compound · Human comparative report · 2008
Parent Selank compared with medazepam
What did this publication test, and what did it find?
- Population / model
- 62 patients with generalized anxiety or neurasthenia in the parent-Selank report.
- Study design
- Clinical comparison of Selank with medazepam using psychometric measures. Randomization and blinding were not established from the abstract.
- Main finding
- The parent-Selank report described similar anxiety-symptom responses across the compared treatments.
- Limits & context
- The intervention was parent Selank. Its report cannot confirm efficacy or safety of N-Acetyl Selank, and abstract-only methods limit interpretation.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 0 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
No additional records were returned by this limited exact-name search. That is not evidence that no research exists; alternative scientific names may need investigation.
Repeat this PubMed search ↗New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety & what remains unknown
The absence of an exact-variant clinical study leaves human safety and formulation questions unresolved.
Evidence boundaries
The intervention was parent Selank. Its report cannot confirm efficacy or safety of N-Acetyl Selank, and abstract-only methods limit interpretation.
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
0 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
No matching video has been identified in the current snapshot.
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
N-Acetyl Selank Amidate (20mg)
BioLongevity Labs · Vendor-labeled research use only
$134.97
Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Did the cited clinical study test N-Acetyl Selank?
- What material, population, and route were actually studied?
- The intervention was parent Selank. Its report cannot confirm efficacy or safety of N-Acetyl Selank, and abstract-only methods limit interpretation.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Did the cited clinical study test N-Acetyl Selank?
No. It tested parent Selank. The citation is clearly labeled related evidence and cannot validate the modified variant.
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.